NBCA LIQUID EMBOLIC SYSTEM 2 631500

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,07 report with the FDA on 2011-08-02 for NBCA LIQUID EMBOLIC SYSTEM 2 631500 manufactured by Cordis Neurovascular, Inc..

Event Text Entries

[2130885] The report received from the field indicated that the physician opened and mixed the n-bca liquid embolic system and ethiodized oil. The physician inspected the mixture and bubbles were noted that would not disperse. The physician felt that the mixture of the glue and oil was not complete and discarded the mixture. The product was not clinically used in the patient. There was no reported patient injury. A new kit was used. Additional information has been requested.
Patient Sequence No: 1, Text Type: D, B5


[9278216] (b)(4). The product is not available for evaluation and testing. Additional information will be submitted within 30 days upon receipt.
Patient Sequence No: 1, Text Type: N, H10


[9398175] After mixing the (b)(4), the mixture had bubbles in it and would not disburse. It was felt that the mixture of glue and oil was not complete. The mixture was discarded and a new kit was used with no reported patient injury. No further information regarding the mixture is available. The product was not returned for inspection. A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing process that can be related to the reported complaint. Review of lot 453484 revealed no anomalies during the manufacturing and inspection processes that can be associated with the reported complaint. No units were rejected during the final assembly of this lot and there were no non-conformances or process monitory excursions for this lot. No other issues were noted that were considered potentially related to the reported complaint. Based on the available information, no conclusion can be made. Based on the device history records review there is no indication of a relationship to the manufacturing process. Therefore, no corrective actions will be taken.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1058196-2011-00395
MDR Report Key2186801
Report Source05,07
Date Received2011-08-02
Date of Report2011-07-07
Date of Event2011-07-06
Date Mfgr Received2011-07-25
Device Manufacturer Date2011-03-01
Date Added to Maude2011-09-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. LINA ALZATE
Manufacturer Street14700 NW 57TH COURT
Manufacturer CityMIAMI LAKES FL 33014
Manufacturer CountryUS
Manufacturer Postal33014
Manufacturer Phone7863136492
Manufacturer G1CORDIS CORPORATION
Manufacturer CityMIAMI LAKES FL 33014
Manufacturer CountryUS
Manufacturer Postal Code33014
Single Use3
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNBCA LIQUID EMBOLIC SYSTEM 2
Generic NameCNV_NBCA (MFE)
Product CodeKGG
Date Received2011-08-02
Model NumberNA
Catalog Number631500
Lot Number453484
ID NumberNA
Device Expiration Date2013-01-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCORDIS NEUROVASCULAR, INC.
Manufacturer Address14700 NW 57TH COURT MIAMI LAKES FL 33014 US 33014


Patients

Patient NumberTreatmentOutcomeDate
10 2011-08-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.